James J. Burns & Company’s Amgen AMGN Stock Holding History

James J. Burns & Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Buy	577 +2	+0.3%	+$685	0.02%	154
2026 Q1	$202K	Buy	+575	New	+$205K	0.03%	148

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

James J. Burns & Company's AMGN Position: Q2 2026 in Review

James J. Burns & Company increased its Amgen (AMGN) stake by 0.35% in Q2 2026, buying an estimated $685 and bringing the position to 577 shares worth $209K. The position accounts for 0.02% of the portfolio, ranked #154.

James J. Burns & Company first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

James J. Burns & Company held 577 shares of Amgen worth $209K as of Q2 2026.
James J. Burns & Company bought 2 Amgen shares in Q2 2026, an estimated $685.
Amgen made up 0.02% of James J. Burns & Company's portfolio in Q2 2026, its #154 holding.
James J. Burns & Company first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on James J. Burns & Company's 13F filing for Q2 2026, filed 6 Aug 2026.